3m

MMM

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding

In their latest 13F (Q3 2026)

See who

Value held

$62.7m

Combined value at quarter end

Last quarter

0 bought

4 sold or trimmed

Price at Q2 ’26 end

$161.91

+11.5% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+33.8%Q3 ’24

-5.6%Q4 ’24

+13.8%Q1 ’25

+3.7%Q2 ’25

+1.9%Q3 ’25

+3.2%Q4 ’25

-9.3%Q1 ’26

+11.5%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

5Q4 ’23

5Q1 ’24

5Q2 ’24

5Q3 ’24

5Q4 ’24

5Q1 ’25

5Q2 ’25

4Q3 ’25

4Q4 ’25

4Q1 ’26

4Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes 3m.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding 3m

Mairs & Power	0.5%$56.6m	$56.6m	Trimmed -0.7%	53 qtrs
Jensen Investment Management	0.1%$4.5m	$4.5m	Trimmed 0.0%	53 qtrs
Dodge & Cox	0.0%$1.2m	$1.2m	Trimmed -1.5%	53 qtrs
Horizon Kinetics	0.0%$437k	$437k	Trimmed -46%	14 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works

From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.

Sort by

Insider purchases and sales of 3m
		Bought or sold				Filing
5 Aug 2026	Chavez Rodriguez Beatriz KarinaGroup President	▼ Sold	3,635	$182.51	$663k	Form 4
23 Jul 2026	Banovetz John PatrickExecutive Vice President	▼ Sold	7,880	$170.44	$1.3m	Form 4
23 Jul 2026	Reinseth Theresa ESr Vice President & CAO	▼ Sold	924	$169.42	$157k	Form 4
22 Jul 2026	Rhodes Kevin HEVP, Chief Legal Off & Secret	▼ Sold	7,669	$171.20	$1.3m	Form 4
22 Jul 2026	Goralski Christian T JrGroup President	▼ Sold	4,902	$170.46	$836k	Form 4

About the company

Sector: Health care · Surgical & Medical Instruments & Apparatus
Incorporated in: Delaware
Financial year ends: 31 December
Shares outstanding: 516m at 30 Jun 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

$31bn2013

$30bn2015

$32bn2017

$32bn2019

$35bn2021

$25bn2023

$25bn2025

3m revenue and net income by year
Year	Revenue	Net income
2025	$25bn	$3.3bn
2024	$25bn	$4.2bn
2023	$25bn	−$7.0bn
2022	$26bn	$5.8bn
2021	$35bn	$5.9bn
2020	$32bn	$5.4bn
2019	$32bn	$4.5bn
2018	$33bn	$5.3bn
2017	$32bn	$4.9bn
2016	$30bn	$5.0bn
2015	$30bn	$4.8bn
2014	$32bn	$5.0bn
2013	$31bn	$4.7bn

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.